Bladder management for the evolving spinal cord injury: Options and considerations

Topics in Spinal Cord Injury Rehabilitation

Volumn 9, Issue 1, 2003, Pages 36-52

  Horton III, John A ^a   Chancellor, Michael B ^a   Labatia, Ihab ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Neurogenic bladder; Spinal cord diseases; Therapy; Urology

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ARGIPRESSIN[1 DEAMINO]; BACLOFEN; BETHANECHOL; BOTULINUM TOXIN A; CYSTOSPAZ M; DANTROLENE; DIAZEPAM; DIBENZALINE; DICYCLOVERINE; DOXAZOSIN; EPHEDRINE; ESTROGEN; FLAVOXATE; HYOSCYAMINE; IMIPRAMINE; LEVSINEX; OXYBUTYNIN; PHENOXYBENZAMINE; PHENYLPROPANOLAMINE; PRAZOSIN; PROPANTHELINE BROMIDE; PSEDOPHED; PSEUDOEPHEDRINE; RESINIFERATOXIN; TAMSULOSIN; TERAZOSIN; TOLTERODINE; UNCLASSIFIED DRUG;

BLADDER CATHETERIZATION; CONSTIPATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG FORMULATION; DRUG MECHANISM; HEADACHE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERTENSION; INCIDENCE; INSOMNIA; MORBIDITY; MORTALITY; MUSCLE WEAKNESS; NEUROGENIC BLADDER; RESPIRATORY DISTRESS; REVIEW; SIDE EFFECT; SPINAL CORD INJURY; TREATMENT PLANNING; TREMOR; UROLOGY; VISUAL DISORDER; XEROSTOMIA;

EID: 0037531608     PISSN: 10820744     EISSN: None     Source Type: Journal    
DOI: 10.1310/A40X-YC5W-U4P8-0UUE     Document Type: Review

References (47)

1. Reznicek SB. Management of incontinence in the elderly. J Gender Specific Med. 2002;5(5):43-48.
2. Hicken BL, Putzke JD, Richards JS. Bladder management and quality of life after spinal cord injury. Am J Phys Med Rehabil. 2001;80(12):916-922.
3. National Spinal Cord Injury Statistical Center. Spinal Cord Injury: Facts and Figures at a Glance. Birmingham, AL: University of Alabama at Birmingham; 2001.
4. Chancellor MB, Yoshimura N. Neural control of the lower urinary tract. In: Walsh, PC, ed. Campbell's Urology. 8th ed. St. Louis, MO: Elsevier Science; 2002.
5. Iwatsubo I. Bladder recovery in patients with traumatic cervical cord injury evaluated by voiding synchronous cystospinchterometry with uroflometry. J Urol. 1981;126(4):503-508.
6. Watanabe T, Rivas, DA, Chancellor, MB. Urodynamics of spinal cord injury. Urol Clin North Am. 1996;23(3):459-474.
7. Sullivan M, Yalla SV. Spinal cord injury and other forms of myeloneuropathies. Prob Urol. 1992;6(4):643-658.
8. Thomas DG, O'Flynn KJ. Spinal cord injury. In: Mundy AR, Stephenson TP, Wein AJ, eds. Urodynamics: Principles, Practice, Application. London, Churchill Livingstone; 1994:345-358.
9. Puri J, Mishra B, Mal A, et al. Catheter associated urinary tract infections in neurology and neurosurgical units. J Infect. 2002;44(3):171-175.
10. Kirshblum SC, Groah SL, McKinley WO, Gittler MS, Steins SA. Spinal cord injury medicine. 1. Etiology, classification and acute medical management. Arch Phys Med Rehabil. 2002;83(suppl 1):S50-57.
11. Wheeler JS Jr, Walter JW. Acute urologic management of the patient with spinal cord injury: initial hospitalization. Urol Clin North Am. 1993;20(3):403-411.
12. The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research consensus statement. January 27-29, 1992. J Am Paraplegia Soc. 1992;15(3):194-204.
13. King RB, Carlson CE, Mervine J, Wu Y, Yarkony GM. Clean and intermittent catheterization methods in hospitalized patients with spinal cord injury. Arch Phys Med Rehabil. 1992;73(9):978-802.
14. Rossier AB, Fam BA, Dibenedeto B, Sarkarati M. Urodynamics in spinal shock patients. J Urol. 1979;122(6):783-787.
15. McCormack M, Infante-Rivard C, Shick E. Agreement between clinical methods of measurement of urinary frequency and functional bladder capacity. Br J UroL 1992;69:17-21.
16. Lapides J, Bobbitt JM. Diagnostic value of bulbocavernosus reflex. JAMA. 1956;162:971-972.
17. Weiss DJ, Freid GW, Chancellor MB, et al. Spinal cord injury and bladder recovery. Arch Phys Med Rehabil. 1996;77:1133-1135.
18. Cardenas DD, Kelly E, Krieger JN, Chapman WH. Residual urine volumes in patients with spinal cord injury: measurement with a portable ultrasound instrument. Arch Phys Med Rehabil. 1988;69(7):514-516.
19. Arnold EP, Fukui J, Anthony A, Utley WL. Bladder function following spinal cord injury: a urodynamic analysis of the outcome. Br J Urol. 1984;56(2):172-177.
20. Gupta S, Sathyan G. Pharmockinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate release oxybutynin. J Clin Pharmacol. 1999;39:22-29.
21. Anderson RU, Mobley D, Blank B, et al. Once a day controlled versus immediate release oxybutynin chloride for urge incontinence. J Urol. 1999;161:1809.
22. Tsai SJ, Lew HL, Date E, Bih LI. Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury. Arch Phys Med Rehabil. 2002;83(5):714-717.
23. Yoshiyama M, de Groat WC. Effect of bilateral hypogastric nerve transection on voiding dysfunction in rats with spinal cord injury. Exp Neurol. 2002;175(1):191-197.
24. Hohenfellner M, Pannek J, et al. Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia. Urology. 2001;58(1):28-32.
25. Kirkham AP, Knight SL, Craggs MD, Casey AT, Shah PJ. Neuromodulation through sacral nerve roots 2 to 4 with a Finetech-Brindley sacral posterior and anterior root stimulator. Spinal Cord. 2002;40(6):272-281.
26. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692-697.
27. Andersson KE. Pharmacology of the lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev. 1993;45:253.
28. Baggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA. 1987;258:236.
29. Rew DA, Rundle JSH. Assessment of the safety of regular DDAVP therapy on primary nocturnal enuresis. Br J Urol. 1989;63:352.
30. Kinn AC, Larsson PO. Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis. Scand J Urol Nephrol. 1990;24:109.
31. Doikno AC, Koppenhoefer R. Bethanechol chloride in neurogenic bladder dysfunction. Urology. 1976;8(5):455-458.
32. Kaplan PE, Nanninga JB, Lal S. Urinary bladder smooth-muscle electrical activity: response to atropine and bethanechol. Arch Phys Med Rehabil. 1978;59(10):454-458.
33. Yalla SV, Di Benedetto M, Blunt KJ, Sethi JM, Fam BA. Urethral striated sphincter responses to electro-bulbocavernosus stimulation. J Urol. 1978;119(3):406-409.
34. Hackler RH, Broecker BH, Klein FA, Brady SM. A clinical experience with dantrolene sodium for external urinary sphincter hypertonicity in spinal cord injured patients. J Urol. 1980;124(1):78-81.
35. Jamil F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal Cord. 2001;39(7):355-361.
36. Sekar PS, Wallace DD, Waites KB, et al. Comparison of long-term renal function after SCI using different urinary management methods. Arch Phys Med Rehabil. 1997;78:992-997.
37. Bennett CJ, Young MN, Adkins RH, Diaz F. Comparison of bladder management complication outcomes in female spinal cord injury patients. J Urol. 1995;153(5):1458-1460.
38. Bakke A, Irgens LM, Malt UF, Hoisaeter PA. Clean intermittent catheterisation-performing abilities, aversive experiences and distress. Paraplegia. 1993;31(5):288-297.
39. Wein AJ, Raezer DM, Benson GS. Management of neurogenic bladder dysfunction in the adult. Urology. 1976;8:432.
40. Perkash I. Management of neurogenic bladder dysfunction following acute traumatic cervical central cord syndrome (incomplete tetraplegia). Paraplegia. 1977;15(1):21-37.
41. Ricottone AR, Pranikoff K, Steinmetz JR, Constantino G. Long-term follow-up of sphincterotomy in the treatment of autonomic dysreflexia. Neurourol Urodyn. 1995;14(1):43-46.
42. Reynard JM, Vass J, Sullivan ME, Mamas M. Sphincterotomy and the treatment of detrusorsphincter dyssynergia: current status, future prospects. Spinal Cord. 2003;41(1):1-11.
43. Kim YH, Bird ET, Priebe M, Boone TB. The role of oxybutynin in spinal cord injured patients with indwelling catheters. J Urol. 1997;158(6):2083-2086.
44. Kaufmann JM, Fam B, Jacobs SC, et al. Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol. 1977;118:967.
45. Van Savage JG, Chancellor MB, Slaughenhaupt B. Transverse re-tubularized illeovesicostomy continent urinary diversion to the umbilicus. Tech Urol. 2000;6(1):29-33.
46. Gudziak MR, Tiguert R, Puri K, Gheiler EL, Triest JA. Management of neurogenic bladder dysfunction with incontinent illeovesicostomy. Urology. 1999;54(6):1008-1011.
47. Jezernik S, Craggs M, Grill WM, Creasey G, Rijkhoff NJ. Electrical stimulation for the treatment of bladder dysfunction: current status and future possibilities. Neurol Res. 2002;24(5):413-430.